CN Patent

CN113943293A — 用于制备作为protac btk降解剂的双官能化合物的方法

Assigned to Baiji Shenzhou Beijing Biotechnology Co ltd · Expires 2022-01-18 · 4y expired

What this patent protects

本文公开了一种用于制备新颖的双官能化合物的方法，所述双官能化合物通过将BTK抑制因子部分与E3连接酶配体部分缀合形成，所述双官能化合物功能是将靶向蛋白募集到E3泛素连接酶以进行降解。

USPTO Abstract

本文公开了一种用于制备新颖的双官能化合物的方法，所述双官能化合物通过将BTK抑制因子部分与E3连接酶配体部分缀合形成，所述双官能化合物功能是将靶向蛋白募集到E3泛素连接酶以进行降解。

Drugs covered by this patent

Patent Metadata

Patent number
CN113943293A
Jurisdiction
CN
Classification
—
Expires
2022-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Baiji Shenzhou Beijing Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.